Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05352256 · ClinicalTrials.gov registry record
Pregistry International Pregnancy Exposure Registry (PIPER)
A clinical trial, sponsored by Pregistry.
- Terminated
- Registry status
- 300
- Enrollment target
NCT05352256 is a clinical trial that was terminated before completion, run by Pregistry. The registered enrollment target is 300 participants.
The verdict
NCT05352256 was terminated before completion, sponsored by Pregistry.
- TERMINATED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The aims of the Pregistry International Pregnancy Exposure Registry (PIPER) are to provide early signals of risk after prenatal exposure to medical products and to define boundaries of safety for medical products. The goal is to assist prescribers and study participants in weighing the potential risks of prenatal treatments on the wellbeing of mother and the unborn offspring. Specifically, the PIPER will estimate the risk of obstetric outcomes (spontaneous abortion, antenatal bleeding, gestational diabetes, gestational hypertension, intrauterine growth restriction, postpartum hemorrhage, fetal distress, uterine rupture, placenta previa, chorioamnionitis, Caesarean delivery, COVID-19), neonatal outcomes (major congenital malformations, low birth weight, neonatal death, neonatal encephalopathy, neonatal infections, neonatal acute kidney injury, preterm birth, respiratory distress in the newborn, small for gestational age, stillbirth, COVID-19), and infant outcomes (developmental milestones \[motor, cognitive, language, social-emotional, and mental health skills\], height, weight, failure to thrive, medical conditions during the first 12 months of life, COVID-19) among pregnant women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2025-07-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05352256
The ClinicalTrials.gov registry entry for NCT05352256 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pregistry, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05352256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05352256 about?
NCT05352256 is a clinical study titled "Pregistry International Pregnancy Exposure Registry (PIPER)". The aims of the Pregistry International Pregnancy Exposure Registry (PIPER) are to provide early signals of risk after prenatal exposure to medical products and to define boundaries of safety for medical products. The goal is to assist prescribers and study participants in weighing the potential ris...
What is the current status of trial NCT05352256?
This trial is currently terminated. The enrollment target is 300 participants. The study started on 2022-10-01. Estimated completion is 2025-07-28.
Who is sponsoring clinical trial NCT05352256?
This trial is sponsored by Pregistry, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.